These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 17953627

  • 1. Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism.
    Arregger AL, Contreras LN, Tumilasci OR, Aquilano DR, Cardoso EM.
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):656-62. PubMed ID: 17953627
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the role of 17beta-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study.
    Szulc P, Claustrat B, Munoz F, Marchand F, Delmas PD.
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):447-57. PubMed ID: 15473877
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of salivary testosterone by liquid chromatography-tandem mass spectrometry: correlation with serum bioavailable testosterone and aging].
    Sakaguchi K, Hasegawa T.
    Rinsho Byori; 2005 May; 53(5):388-94. PubMed ID: 15966401
    [Abstract] [Full Text] [Related]

  • 4. Decline of serum levels of free testosterone in aging healthy Chinese men.
    Li JY, Li XY, Li M, Zhang GK, Ma FL, Liu ZM, Zhang NY, Meng P.
    Aging Male; 2005 May; 8(3-4):203-6. PubMed ID: 16390747
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of hypogonadism in the aging male.
    Vermeulen A, Kaufman JM.
    Aging Male; 2002 Sep; 5(3):170-6. PubMed ID: 12471777
    [Abstract] [Full Text] [Related]

  • 6. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo.
    Flyckt RL, Liu J, Frasure H, Wekselman K, Buch A, Kingsberg SA.
    Menopause; 2009 Sep; 16(4):680-8. PubMed ID: 19325500
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of direct and indirect markers to assess the androgen status in healthy males during aging.
    Elmlinger MW, Kühnel W, Döller PC.
    Clin Lab; 2006 Sep; 52(9-10):491-6. PubMed ID: 17078476
    [Abstract] [Full Text] [Related]

  • 8. Hypogonadism in male patients with cancer.
    Garcia JM, Li H, Mann D, Epner D, Hayes TG, Marcelli M, Cunningham GR.
    Cancer; 2006 Jun 15; 106(12):2583-91. PubMed ID: 16688773
    [Abstract] [Full Text] [Related]

  • 9. Validation of salivary testosterone as a screening test for male hypogonadism.
    Morley JE, Perry HM, Patrick P, Dollbaum CM, Kells JM.
    Aging Male; 2006 Sep 15; 9(3):165-9. PubMed ID: 17050116
    [Abstract] [Full Text] [Related]

  • 10. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease.
    Cardoso EM, Contreras LN, Tumilasci EG, Elbert A, Aguirre EC, Aquilano DR, Arregger AL.
    Nephrol Dial Transplant; 2011 Feb 15; 26(2):677-83. PubMed ID: 20659904
    [Abstract] [Full Text] [Related]

  • 11. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations.
    Rinaldi S, Geay A, Déchaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Riboli E, Toniolo P, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 15; 11(10 Pt 1):1065-71. PubMed ID: 12376508
    [Abstract] [Full Text] [Related]

  • 12. When is bioavailable testosterone a redundant test in the diagnosis of hypogonadism in men?
    Gheorghiu I, Moshyk A, Lepage R, Ahnadi CE, Grant AM.
    Clin Biochem; 2005 Sep 15; 38(9):813-8. PubMed ID: 15961071
    [Abstract] [Full Text] [Related]

  • 13. Does early morning versus late morning draw time influence apparent testosterone concentration in men aged > or =45 years? Data from the Hypogonadism In Males study.
    Guay A, Miller MG, McWhirter CL.
    Int J Impot Res; 2008 Sep 15; 20(2):162-7. PubMed ID: 17637790
    [Abstract] [Full Text] [Related]

  • 14. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?
    Blümel JE, Chedraui P, Gili SA, Navarro A, Valenzuela K, Vallejo S.
    Maturitas; 2009 Aug 20; 63(4):365-8. PubMed ID: 19481382
    [Abstract] [Full Text] [Related]

  • 15. Undetectable salivary testosterone in young women with premature ovarian failure.
    Mason A, Wallace AM, Macintyre H, Teoh YP, Bath LE, Critchley HO, Kelnar CJ, Wallace WH, Ahmed SF.
    Clin Endocrinol (Oxf); 2006 Jun 20; 64(6):711-4. PubMed ID: 16712676
    [Abstract] [Full Text] [Related]

  • 16. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
    Kapoor D, Aldred H, Clark S, Channer KS, Jones TH.
    Diabetes Care; 2007 Apr 20; 30(4):911-7. PubMed ID: 17392552
    [Abstract] [Full Text] [Related]

  • 17. Functional testosterone: biochemical assessment of hypogonadism in men--report from a multidisciplinary workshop hosted by the Ontario Society of Clinical Chemists.
    Collier CP, Clark AF, Bain J, Godwin M, Hudson RW, Lepage R, Morales A, Moses G, Tremblay RR, Vandenberghe H.
    Aging Male; 2007 Dec 20; 10(4):211-6. PubMed ID: 18033630
    [Abstract] [Full Text] [Related]

  • 18. [Serum and salivary testosterone levels in erectile dysfunction].
    Corradi G, Szathmári M.
    Orv Hetil; 1998 Aug 23; 139(34):2021-4. PubMed ID: 9745307
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status.
    Goncharov N, Katsya G, Dobracheva A, Nizhnik A, Kolesnikova G, Herbst V, Westermann J.
    Aging Male; 2006 Jun 23; 9(2):111-22. PubMed ID: 16916746
    [Abstract] [Full Text] [Related]

  • 20. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP, Scane AC, Fraser WD, Diver MJ, Eastell R, Francis RM.
    Bone; 2008 Dec 23; 43(6):999-1005. PubMed ID: 18817902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.